02045nam a2200373Ia 4500001001200000003000600012005001700018007001400035008004100049020001500090020001800105040006300123043001200186050002200198074001600220086002900236110016800265245017800433260011300611300002800724336002600752337002700778338003100805490002300836500003600859500002500895533007000920650006000990650005301050650004801103776023801151776022201389810006001611ocm46946854OCoLC20170314095353.0he bmb024bbca010515s2000    dcu     b    f000 0 eng d  a0160644984  a9780160644986  aMSTbengcMSTdOCLCQdFXGBLdOCLCQdOCLCOdOCLCQdGPOdMvI  an-us---14aKF26b.A653 2000f  a1033-A (MF)0 aY 4.AP 6/2:S.HRG.106-7421 aUnited States.bCongress.bSenate.bCommittee on Appropriations.bSubcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.10aAlternative medicines :bhearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Sixth Congress, second session, special hearing.  aWashington :bU.S. G.P.O. :bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,c2000.  aiii, 65 pages ;c23 cm.  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier1 aS. hrg. ;v106-742  aShipping list no.: 2001-0204-M.  aCRDP Program record.  aMicrofiche.b[Washington] :cSupt Docs/GPO,d2001.e1 microfiche. 0aAlternative medicinexResearchzUnited StatesxFinance. 0aMind and bodyxResearchzUnited StatesxFinance. 0aMedicinexResearchzUnited StatesxFinance.08iPrint version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tAlternative medicinesw(DLC) 2001315697w(OCoLC)4579090008iOnline version:aUnited States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies.tAlternative medicinesw(OCoLC)9405194331 aUnited States.bCongress.bSenate.tS. hrg. ;v106-742.